Cargando…
Myocardial Strain Imaging in Resistant Hypertension
PURPOSE OF REVIEW: Resistant hypertension (RH) is a major contributor to cardiovascular diseases and is associated with increased all-cause and cardiovascular mortality. Cardiac changes such as impaired left ventricular (LV) function, left ventricular hypertrophy (LVH), myocardial fibrosis, and enla...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099817/ https://www.ncbi.nlm.nih.gov/pubmed/33950321 http://dx.doi.org/10.1007/s11906-021-01148-3 |
_version_ | 1783688653377110016 |
---|---|
author | Alsharari, Reem Oxborough, David Lip, Gregory Y. H. Shantsila, Alena |
author_facet | Alsharari, Reem Oxborough, David Lip, Gregory Y. H. Shantsila, Alena |
author_sort | Alsharari, Reem |
collection | PubMed |
description | PURPOSE OF REVIEW: Resistant hypertension (RH) is a major contributor to cardiovascular diseases and is associated with increased all-cause and cardiovascular mortality. Cardiac changes such as impaired left ventricular (LV) function, left ventricular hypertrophy (LVH), myocardial fibrosis, and enlarged left atrium (LA) are consequences of chronic exposure to an elevated blood pressure. The purpose of this review article is to demonstrate the potential benefits of using STE as a non-invasive imaging technique in the assessment of cardiac remodeling in patients with hypertension and specifically in uncontrolled and RH population. RECENT FINDINGS: It is well-recognized that conventional transthoracic echocardiography is a useful analytic imaging modality to evaluate hypertension-mediated organ damage (HMOD) and in a resistant hypertensive population. More recently two-dimensional speckle tracking echocardiography (STE) has been utilized to provide further risk assessment to this population. SUMMARY: Recent data has shown that STE is a new promising echocardiographic marker to evaluate early stage LV dysfunction and myocardial fibrosis over conventional 2D parameters in patients with cardiovascular diseases. |
format | Online Article Text |
id | pubmed-8099817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-80998172021-05-11 Myocardial Strain Imaging in Resistant Hypertension Alsharari, Reem Oxborough, David Lip, Gregory Y. H. Shantsila, Alena Curr Hypertens Rep Resistant Hypertension (L Drager, Section Editor) PURPOSE OF REVIEW: Resistant hypertension (RH) is a major contributor to cardiovascular diseases and is associated with increased all-cause and cardiovascular mortality. Cardiac changes such as impaired left ventricular (LV) function, left ventricular hypertrophy (LVH), myocardial fibrosis, and enlarged left atrium (LA) are consequences of chronic exposure to an elevated blood pressure. The purpose of this review article is to demonstrate the potential benefits of using STE as a non-invasive imaging technique in the assessment of cardiac remodeling in patients with hypertension and specifically in uncontrolled and RH population. RECENT FINDINGS: It is well-recognized that conventional transthoracic echocardiography is a useful analytic imaging modality to evaluate hypertension-mediated organ damage (HMOD) and in a resistant hypertensive population. More recently two-dimensional speckle tracking echocardiography (STE) has been utilized to provide further risk assessment to this population. SUMMARY: Recent data has shown that STE is a new promising echocardiographic marker to evaluate early stage LV dysfunction and myocardial fibrosis over conventional 2D parameters in patients with cardiovascular diseases. Springer US 2021-05-05 2021 /pmc/articles/PMC8099817/ /pubmed/33950321 http://dx.doi.org/10.1007/s11906-021-01148-3 Text en © Crown 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Resistant Hypertension (L Drager, Section Editor) Alsharari, Reem Oxborough, David Lip, Gregory Y. H. Shantsila, Alena Myocardial Strain Imaging in Resistant Hypertension |
title | Myocardial Strain Imaging in Resistant Hypertension |
title_full | Myocardial Strain Imaging in Resistant Hypertension |
title_fullStr | Myocardial Strain Imaging in Resistant Hypertension |
title_full_unstemmed | Myocardial Strain Imaging in Resistant Hypertension |
title_short | Myocardial Strain Imaging in Resistant Hypertension |
title_sort | myocardial strain imaging in resistant hypertension |
topic | Resistant Hypertension (L Drager, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099817/ https://www.ncbi.nlm.nih.gov/pubmed/33950321 http://dx.doi.org/10.1007/s11906-021-01148-3 |
work_keys_str_mv | AT alshararireem myocardialstrainimaginginresistanthypertension AT oxboroughdavid myocardialstrainimaginginresistanthypertension AT lipgregoryyh myocardialstrainimaginginresistanthypertension AT shantsilaalena myocardialstrainimaginginresistanthypertension |